Avicanna
Logotype for Avicanna Inc

Avicanna (AVCN) investor relations material

Avicanna Life Sciences Virtual Investor Forum summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Avicanna Inc
Life Sciences Virtual Investor Forum summary12 Mar, 2026

Company overview and business model

  • Focused on evidence-based cannabinoid medicines for unmet medical needs, with four commercial divisions: medical cannabis products, a telemedicine platform, a pharmaceutical pipeline, and a raw material/API division.

  • Emphasizes medical and pharmaceutical applications, not recreational cannabis, targeting pain, sleep, anxiety, dermatology, oncology, and neurological disorders.

  • Operates MyMedi.ca, an online pharmacy/telemedicine platform providing patient support, treatment planning, and medical affairs, considered a gold standard in Canada.

  • Owns and supplies its own active pharmaceutical ingredients from Colombia, offering cost and quality advantages.

  • Commercializes products in over 20 countries, focusing on federally regulated medical and pharmaceutical markets.

Research, development, and intellectual property

  • Originated as a drug development company, spending initial years on R&D and clinical development, including collaborations with leading academic and clinical institutions.

  • Developed proprietary drug delivery technologies, such as nano-emulsion, now used in commercial products and protected by patents.

  • Holds several USPTO patents and a significant number of pipeline products submitted for patent approval, all developed in-house.

  • Clinical data and real-world evidence from platforms like MyMedi inform product development and support regulatory submissions.

  • Intellectual property and clinical credibility have attracted partnerships with Fortune 100 and 500 companies.

Pharmaceutical pipeline and clinical progress

  • Four major drug candidates in development, targeting sleep, rare skin diseases, pain management, anxiety/depression, and epilepsy.

  • Trunerox, the first approved pharmaceutical, launched in Colombia for Lennox-Gastaut syndrome, with plans to expand to other markets.

  • Phase 2 clinical trial for osteoarthritic pain underway at Toronto General Hospital/UHN, with data expected to drive further value and partnerships.

  • Additional topicals for rare skin diseases and inflammatory pain are in advanced development.

  • Plans to collaborate with larger pharmaceutical companies for late-stage clinical development and commercialization.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
Research faster. Power your platform.

Next Avicanna earnings date

Logotype for Avicanna Inc
Q4 202531 Mar, 2026
Avicanna
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Avicanna earnings date

Logotype for Avicanna Inc
Q4 202531 Mar, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Avicanna Inc. is a Canadian international commercial-stage biopharmaceutical company focused on the development, advancement, and commercialization of evidence-based cannabinoid-based products. The company operates in the global medical and pharmaceutical market segments, leveraging its established scientific platform, including research and development (R&D) and clinical development. This platform has enabled Avicanna to launch over thirty proprietary products, along with a robust pharmaceutical pipeline aimed at addressing a range of medical conditions. Avicanna's business strategy encompasses active and commercial business pillars that include medical cannabis and wellness products, as well as a medical cannabis care portal. The company is headquartered in Toronto, Canada, and its shares are listed on the Toronto Stock Exchange.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage